HAE — Haemonetics Corporation
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Haemonetics Corporation (HAE), worth $10.39M combined. Over the quarter 2 opened or added, 1 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $9.75M | 0.01% | +200.9% |
| Kohlberg | $381.94K | 0.00% | -49.5% |
| Caxton Associates | $256.95K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.